A Clinical Trial on the Treatment of Idiopathic Pulmonary Fibrosis

Summary

This trial was performed in patients with idiopathic pulmonary fibrosis (IPF) to evaluate the clinical efficacy and safety of different doses of TDI01 Suspension, compared with control, for the treatment of patients with IPF.

Timeline

Start

2023-11-02

Primary completion

2025-08-01

Completion

2026-03-01

Drugs

Indications